Literature DB >> 8184784

Excitation-contraction coupling and contractile protein function in failing and nonfailing human myocardium.

G Hasenfuss1, B Pieske, C Holubarsch, N R Alpert, H Just.   

Abstract

Isometric force, heat output, and aequorin light emission were measured in isolated muscle strips from nonfailing human hearts and from hearts with endstage failing dilated cardiomyopathy (37 degrees C; 30-180 beats per minute (bpm)). In nonfailing myocardium, peak twitch tension increased with higher rates of stimulation, whereas the force-frequency relation was inverse in the failing myocardium. At 60 bpm and at higher rates of stimulation, peak twitch tension was reduced significantly in the failing myocardium. Myothermal measurements, performed at 60 bpm, indicated that the number of crossbridge interactions and the amount of calcium cycling are reduced significantly in the failing myocardium. Furthermore, aequorin light transients indicated that the inverse force-frequency relation in failing myocardium results from altered calcium cycling; with increasing rates of stimulation aequorin light emission increased continuously in the nonfailing and decreased continuously in the failing myocardium. The data suggest that impaired myocardial performance in failing human myocardium may result primarily from disturbed excitation-contraction coupling processes with a reduced amount of calcium cycling and, thus, a decreased activation of contractile proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8184784     DOI: 10.1007/978-1-4615-2946-0_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  Targeting calcium cycling proteins in heart failure through gene transfer.

Authors:  Federica del Monte; Roger J Hajjar
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

Review 2.  Remodeling of calcium handling in human heart failure.

Authors:  Qing Lou; Ajit Janardhan; Igor R Efimov
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure.

Authors:  Qing Lou; Vadim V Fedorov; Alexey V Glukhov; Nader Moazami; Vladimir G Fast; Igor R Efimov
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

Review 4.  Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy.

Authors:  T Jake Samuel; Ryan P Rosenberry; Seungyong Lee; Zui Pan
Journal:  Int J Mol Sci       Date:  2018-04-05       Impact factor: 5.923

Review 5.  Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias.

Authors:  Alexandra Njegic; Claire Wilson; Elizabeth J Cartwright
Journal:  Front Physiol       Date:  2020-09-04       Impact factor: 4.566

6.  CRISPLD1: a novel conserved target in the transition to human heart failure.

Authors:  Sara Khadjeh; Vanessa Hindmarsh; Frederike Weber; Lukas Cyganek; Ramon O Vidal; Setare Torkieh; Katrin Streckfuss-Bömeke; Dawid Lbik; Malte Tiburcy; Belal A Mohamed; Stefan Bonn; Karl Toischer; Gerd Hasenfuss
Journal:  Basic Res Cardiol       Date:  2020-03-07       Impact factor: 17.165

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.